Search results - ORA - Oxford University Research Archive

1 - 19 of 19

1

Journal article

Airway proteomics reveals broad residual anti-inflammatory effects of prednisolone in mepolizumab-treated asthma

Howell, I, Yang, F, Brown, V, et al.
2024-08-02

2

Journal article

Longitudinal changes in sputum and blood inflammatory mediators during FeNO suppression testing

Couillard, S, Shrimanker, R, Lemaire-Paquette, S, et al.
2022-07-07

3

Journal article

Identifying bacterial airways infection in stable severe asthma using Oxford nanopore sequencing technologies

Jabeen, MF, Sanderson, N, Foster, D, et al.
2022-03-24

4

Conference item

Utility of adherence checks in patients with severe asthma eligible for biologics: a single centre retrospective analysis

Oliver, ME, Poole, S, Borg, C, et al.
2021-11-08

5

Journal article

Asthma in pregnancy: An update

Couillard, S, Connolly, C, Borg, C, et al.
2020-11-01

6

Conference item

Mechanisms of FeNO non-suppression in severe asthma: analysis of sputum type 2 cytokines and chemokines

Couillard, S, Shrimanker, R, Hynes, G, et al.
2020-09-07

7

Conference item

Depletion rate of blood eosinophils with mepolizumab, benralizumab and oral prednisolone in patients with severe asthma

Moran, A, Ramakrishnan, S, Borg, C, et al.
2020-10-28

8

Conference item

Clinical outcomes with mepolizumab therapy in routine practice in the oxford cohort

Gittins, A, Borg, C, Connolly, C, et al.
2018-12-01

9

Journal article

How health-related quality of life assessment should be used in advanced colorectal cancer clinical trials

Bonnetain, F, Borg, C, Adams, R, et al.
2017-04-18

10

Conference item

Evaluating the sensitivity and specificity of Neatstik® technology compared to an activity-based immunoassay in sputum samples

Thulborn, S, Cane, J, Connolly, C, et al.
2018-05-23

11

Conference item

Identification of pulmonary treatable traits in a real-life setting

Simpson, J, Shrimanker, R, Thulborn, S, et al.
2018-11-19

12

Conference item

Type-2 CD8+ T lymphocytes responsive to PGD2/LTE4 in severe eosinophilic asthma

Hinks, T, Hilvering, B, Stoger, L, et al.
2018-11-19

13

Conference item

The effect of oral corticosteroids on circulating type-2 cytokine producing cells in patients with severe eosinophilic asthma

Hynes, G, Go, S, Luo, J, et al.
2018-12-01

14

Conference item

Lung attacks in the ED: measurements to predict outcome. The AWARD study

Russell, R, Bafadhel, M, Pavord, I, et al.
2017-09-01

15

Conference item

Can NPT be used to distinguish eosinophilic inflammatory phenotypes in COPD?

Hambleton, K, Borg, C, Connolly, C, et al.
2016-11-08

16

Journal article

Synergistic activation of pro-inflammatory type-2 CD8+ T lymphocytes by lipid mediators in severe eosinophilic asthma

Hilvering, B, Hinks, T, Stoeger, L, et al.
2018-06-15

17

Journal article

Comparison of the peripheral blood eosinophil count using near-patient testing and standard automated laboratory measurement in healthy, asthmatic and COPD subjects

Hambleton, K, Connolly, C, Borg, C, et al.
2017-09-01

18

Conference item

Sputum Il-17a levels correlate with biomarkers of non-eosinophilic inflammation in patients with asthma

Hynes, G, Go, S, Thulborn, S, et al.
2017-05-23

19

Conference item

The peripheral blood eosinophil count as a biomarker of eosinophilic airway inflammation in patients with asthma and COPD. Experience from a single centre

Shrimanker, R, Thulborn, S, Mistry, V, et al.
2017-05-23

TO TOP